Morgan Stanley
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Morgan Stanley in real time with a live news feed covering Morgan Stanley stock news, official press releases, company announcements, and an archive of historical Morgan Stanley news. ...more
Loading news...
Loading more...
4:21 PM | Friday | May 22, 2026
Sign in to download news snippet
Morgan Stanley stock is in a buy zone of a base. A biometric identity name hit a new high after rebounding following a sell signal.
Read full articleNo data available for this time period.
Change the time range to see results.
Morgan Stanley stock is in a buy zone of a base. A biometric identity name hit a new high after rebounding following a sell signal.
Read full article
Morgan Stanley is upgraded to a 'Buy', driven by robust top-line growth, margin recovery, and strong competitive positioning. Morgan Stanley demonstrates proven revenue growth, positive client inflows, and benefits from M&A and resilient equity markets, supporting its diversified business model. Despite signs of overvaluation and modest 7% upside forecasts, its A-level credit ratings, strong liquidity, and low payout ratio reinforce its quality profile.
Read full article
Morgan Stanley is upgraded to a 'Buy', driven by robust top-line growth, margin recovery, and strong competitive positioning. Morgan Stanley demonstrates proven revenue growth, positive client inflows, and benefits from M&A and resilient equity markets, supporting its diversified business model. Despite signs of overvaluation and modest 7% upside forecasts, its A-level credit ratings, strong liquidity, and low payout ratio reinforce its quality profile.
Read full article
In the most recent trading session, Morgan Stanley (MS) closed at $200.51, indicating a +1.39% shift from the previous trading day.
Read full article
NEW YORK--(BUSINESS WIRE)--Morgan Stanley (NYSE: MS) today announced the winners of its 17th annual Strategy Challenge, the Firm's flagship pro bono program which brings together rising talent to help nonprofits solve strategic, mission-critical challenges. The winning teams supported Hour Children in the U.S. and Mental Health Innovations in the UK. Over the past 10 weeks, Morgan Stanley employees provided in-depth, pro bono consulting services to 14 nonprofits on topics such as expanding prog.
When tech stocks are flying high, it can be easy to forget about the steady, dividend-paying stocks that often stabilize a portfolio.
Read full article
Morgan Stanley has asked its Hong Kong-based bankers to carry new mobile devices issued exclusively for business travel to mainland China, as international firms with a cross-border workforce tighten data security.
Read full article
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics, the architect of the Locksmith® platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead Passkey's clinical and medical strategy as it advances a series of Locksmith-identified drug combinations into clinical studies across multiple therapeutic areas. Dr.
Kaur most recently served as Senior.
The financial services giant saw a 48% increase in investment banking fees in Q1.
Read full article
[url="]Morgan Stanley at Work[/url] today issued new data from its sixth annual State of the Workplace Financial Benefits Study. The research reveals workpla
Read full article
NEW YORK--(BUSINESS WIRE)--Morgan Stanley at Work today issued new data from its sixth annual State of the Workplace Financial Benefits Study. The research reveals workplace financial benefits are a powerful driver of employee satisfaction, engagement and retention, especially as a tighter job market, AI disruption and rising costs influence expectations for employer support. Financial stress remains a persistent challenge, fueling demand for practical planning guidance and help in maximizing e.
Read full article
Kiplinger's Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide open across the entire risk spectrum. We are seeing a massive spread, with opportunities ranging from stable 3% municipal bonds to 13% for those willing to get aggressive with business development companies. This is unfolding...
Kiplinger's May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
No data available for this time period.
Change the time range to see results.